Expert discusses how emerging technologies like at-home testing and AI are redefining CKD screening and prevention for the ...

Expert discusses how health care teams must empower patients through ongoing dialogue, emphasizing shared decision-making and ...

Expert discusses how chronic kidney disease ( CKD) and cardiovascular disease are interlinked, requiring proactive management ...

Sanofi is expanding options for those with hemophilia with its new treatment, Qfitlia (fitusiran). Approved this year, ...

Jeff Schaffnit discusses Sanofi's advancements in BTK inhibitors and promising results for hemophilia A therapies at ASH 2025 ...

The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...

Clinicians are moving toward managing mild (Grade 1) cytokine release syndrome on an outpatient basis. The most common and ...

The CAR T Vision Steering Committee members wish to double the number of eligible patients receiving chimeric antigen ...

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

A modified immunotherapy regimen for advanced melanoma showed a 49% response rate and extended median overall survival to 42 ...

As the number of patients with multiple myeloma and lymphoma treated with CAR-T therapy increases, health systems are ...

Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.